Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive 40Leukemia, Myeloid, Chronic-Phase 14Precursor Cell Lymphoblastic Leukemia-Lymphoma 6Leukemia 5Blast Crisis 5Neoplasm Metastasis 3Melanoma 3Leukemia, Myeloid, Acute 3Gastrointestinal Stromal Tumors 3Synovitis, Pigmented Villonodular 2Recurrence 2Leukemia, Myeloid, Accelerated Phase 2Substance Withdrawal Syndrome 1Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1Neurofibromatoses 1Neurofibroma, Plexiform 1Neurofibroma 1Neoplasms 1Neoplasm, Residual 1Mucosal Lentiginous Melanoma 1Lymphoma, T-Cell, Peripheral 1Lymphoma, Non-Hodgkin 1Head and Neck Neoplasms 1Glioma 1Giant Cell Tumor of Tendon Sheath 1Gastrointestinal Neoplasms 1Colorectal Neoplasms 1Colonic Neoplasms 1Chordoma 1Carcinoma, Squamous Cell 1

Interventions

nilotinib 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Synovitis, Pigmented Villonodular × nilotinib × Clear all
NCT01207492 2026-02-20

Nilotinib in Patients With Relapsed or Metastatic Pigmented Villonodular Synovitis/Tenosynovial Giant Cell Tumor/Diffuse-Type Giant Cell Tumor

Dana-Farber Cancer Institute

Phase 2 Completed
17 enrolled 8 charts

Giant Cell Tumor of Tendon Sheath, Synovitis, Pigmented Villonodular

NCT01261429 2013-04-16

Study of Nilotinib Efficacy in Pigmented Villo-Nodular Synovitis/ Tenosynovial Giant Cell Tumour (PVNS/TGCT)

Centre Leon Berard

Phase 2 Completed
50 enrolled

Synovitis, Pigmented Villonodular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡